The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice

JF Cryan, C Mombereau, A Vassout - Neuroscience & Biobehavioral …, 2005 - Elsevier
Since its introduction almost 20 years ago, the tail suspension test has become one of the
most widely used models for assessing antidepressant-like activity in mice. The test is based …

Caffeine and adenosine

JA Ribeiro, AM Sebastiao - Journal of Alzheimer's disease, 2010 - content.iospress.com
Caffeine causes most of its biological effects via antagonizing all types of adenosine
receptors (ARs): A1, A2A, A3, and A2B and, as does adenosine, exerts effects on neurons …

Assessing antidepressant activity in rodents: recent developments and future needs

JF Cryan, A Markou, I Lucki - Trends in pharmacological sciences, 2002 - cell.com
Animal models are indispensable tools in the search to identify new antidepressant drugs
and to provide insights into the neuropathology that underlies the idiopathic disease state of …

Comorbidity of insomnia and depression

L Staner - Sleep medicine reviews, 2010 - Elsevier
During the last decade, several studies have shown that insomnia, rather than a symptom of
depression, could be a medical condition on its own, showing high comorbidity with …

[HTML][HTML] Focusing on adenosine receptors as a potential targeted therapy in human diseases

WI Effendi, T Nagano, K Kobayashi, Y Nishimura - Cells, 2020 - mdpi.com
Adenosine is involved in a range of physiological and pathological effects through
membrane-bound receptors linked to G proteins. There are four subtypes of adenosine …

[HTML][HTML] Mechanism of action of atypical antipsychotic drugs in mood disorders

D Grinchii, E Dremencov - International Journal of Molecular Sciences, 2020 - mdpi.com
Atypical antipsychotic drugs were introduced in the early 1990s. Unlike typical
antipsychotics, which are effective only against positive symptoms of schizophrenia, atypical …

Adenosine A2A Receptor as a Drug Discovery Target

M de Lera Ruiz, YH Lim, J Zheng - Journal of medicinal chemistry, 2014 - ACS Publications
The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been
extensively studied during the past few decades because it offers numerous possibilities for …

Adenosine and brain function

BB Fredholm, JF Chen, RA Cunha… - Int Rev …, 2005 - books.google.com
A. Cellular and Subcellular Localization B. Pharmacological Tools to Study Adenosine
Receptors C. Signaling Via Adenosine Receptors D. Regulation of Receptor Expression and …

[HTML][HTML] Adenosine receptors and brain diseases: neuroprotection and neurodegeneration

CV Gomes, MP Kaster, AR Tomé, PM Agostinho… - … et Biophysica Acta (BBA …, 2011 - Elsevier
Adenosine acts in parallel as a neuromodulator and as a homeostatic modulator in the
central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory …

[HTML][HTML] ATP and adenosine—Two players in the control of seizures and epilepsy development

E Beamer, M Kuchukulla, D Boison, T Engel - Progress in neurobiology, 2021 - Elsevier
Despite continuous advances in understanding the underlying pathogenesis of
hyperexcitable networks and lowered seizure thresholds, the treatment of epilepsy remains …